| scholarly article | Q13442814 |
| P50 | author | Samantha J Lycett | Q56384148 |
| Vasiliki Bitsouni | Q60393480 | ||
| P2093 | author name string | Andrea Doeschl-Wilson | |
| Tanja Opriessnig | |||
| P2860 | cites work | Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects | Q26825847 |
| Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines | Q27472342 | ||
| Current Status of Veterinary Vaccines | Q27480923 | ||
| Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination | Q28071014 | ||
| A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data | Q28383049 | ||
| Modelling vaccination strategies against foot-and-mouth disease. | Q52025418 | ||
| Modelling the economic efficiency of using different strategies to control Porcine Reproductive & Respiratory Syndrome at herd level. | Q52646371 | ||
| Imperfect vaccination: some epidemiological and evolutionary consequences. | Q55110020 | ||
| Reactive vaccination in the presence of disease hotspots | Q56762397 | ||
| Can We Breed Cattle for Lower Bovine TB Infectivity? | Q60305521 | ||
| Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV | Q80209205 | ||
| Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus (MLV) vaccine strains in a young pig infection model | Q39815042 | ||
| Improved Vaccine against PRRSV: Current Progress and Future Perspective | Q40046407 | ||
| Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions | Q41144502 | ||
| Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model | Q41640514 | ||
| Stochastic model of porcine reproductive and respiratory syndrome virus control strategies on a swine farm in the United States | Q42227294 | ||
| Enhancing neutralizing antibody production by an interferon-inducing porcine reproductive and respiratory syndrome virus strain. | Q42267326 | ||
| Quasispecies variation of porcine reproductive and respiratory syndrome virus during natural infection | Q42616368 | ||
| Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations | Q42650574 | ||
| Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs | Q45361920 | ||
| Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs | Q45404505 | ||
| Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge | Q45406008 | ||
| Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows. | Q45413398 | ||
| Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells | Q45666619 | ||
| Risk factors for infection of sow herds with porcine reproductive and respiratory syndrome (PRRS) virus | Q45733896 | ||
| Introduction, persistence and fade-out of porcine reproductive and respiratory syndrome virus in a Dutch breeding herd: a mathematical analysis | Q45743752 | ||
| A stochastic mathematical model of the within-herd transmission dynamics of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): fade-out and persistence. | Q45956254 | ||
| Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts | Q47725932 | ||
| Porcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic. | Q30364184 | ||
| Modeling the effects of vaccination and treatment on pandemic influenza | Q30403597 | ||
| A unifying theory for genetic epidemiological analysis of binary disease data. | Q30760174 | ||
| Network, cluster and risk factor analyses for porcine reproductive and respiratory syndrome using data from swine sites participating in a disease control program. | Q31103553 | ||
| Land altitude, slope, and coverage as risk factors for Porcine Reproductive and Respiratory Syndrome (PRRS) outbreaks in the United States | Q33570425 | ||
| Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development | Q33930291 | ||
| Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens | Q34044564 | ||
| New technology for improved vaccine safety and efficacy. | Q34427357 | ||
| Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau | Q34474623 | ||
| Duration of infection and proportion of pigs persistently infected with porcine reproductive and respiratory syndrome virus | Q34746737 | ||
| Unapparent foot and mouth disease infection (sub-clinical infections and carriers): implications for control. | Q35043524 | ||
| The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods | Q35122248 | ||
| Economic Analysis of Immunization Strategies for PRRS Control [corrected] | Q35870403 | ||
| Genetic variation and responses to vaccines | Q36177344 | ||
| Evaluation of Control Strategies for Porcine Reproductive and Respiratory Syndrome (PRRS) in Swine Breeding Herds Using a Discrete Event Agent-Based Model | Q36201071 | ||
| Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus | Q36390103 | ||
| Infectiousness of pigs infected by the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is time-dependent | Q36397345 | ||
| The challenge for the next generation of feline calicivirus vaccines. | Q36477649 | ||
| Control of porcine reproductive and respiratory syndrome (PRRS) through genetic improvements in disease resistance and tolerance | Q36591804 | ||
| The evolutionary epidemiology of vaccination | Q36671958 | ||
| The challenge of PRRS immunology. | Q36888431 | ||
| Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger | Q37020372 | ||
| Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars | Q37224040 | ||
| Distinguishing vaccine efficacy and effectiveness | Q37233120 | ||
| Model for assessing human papillomavirus vaccination strategies | Q37302509 | ||
| Acute infectious bursal disease in poultry: a review | Q37382392 | ||
| Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology | Q37493297 | ||
| Porcine reproductive and respiratory syndrome in China | Q37775726 | ||
| Control and elimination of porcine reproductive and respiratory syndrome virus | Q37788339 | ||
| Taming PRRSV: revisiting the control strategies and vaccine design | Q37790146 | ||
| Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). | Q37934055 | ||
| Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine | Q38076180 | ||
| A review of vaccine development and research for industry animals in Korea | Q38099839 | ||
| Recent developments in livestock and wildlife brucellosis vaccination. | Q38120274 | ||
| Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): Pathogenesis and Interaction with the Immune System. | Q38662643 | ||
| Effective vaccination against long-term gammaherpesvirus latency | Q39700306 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P304 | page(s) | e0220738 | |
| P577 | publication date | 2019-08-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs | |
| P478 | volume | 14 |
| Q98771966 | Modeling Economic Effects of Vaccination Against Porcine Reproductive and Respiratory Syndrome: Impact of Vaccination Effectiveness, Vaccine Price, and Vaccination Coverage |
| Q98726777 | Modelling infectious viral diseases in swine populations: a state of the art |
| Q89981737 | New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission |
| Q90064898 | Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence |
Search more.